{"agranulocytosis": 5.84, "anaphylactic reaction": 2.9, "anaphylactic shock": 4.99, "autoimmune haemolytic anaemia": 19.47, "bronchospasm": 9.94, "dermatomyositis": 66.46, "drug effective for unapproved indication": 50.88, "erythema": 3.09, "face oedema": 3.16, "flushing": 3.32, "haemolytic anaemia": 8.4, "hypersensitivity": 4.52, "hypotension": 4.46, "hypoxia": 10.28, "immune thrombocytopenia": 33.02, "infusion related reaction": 25.98, "insurance issue": 56.19, "intentional dose omission": 20.94, "intentional product use issue": 5.51, "mantle cell lymphoma": 497.43, "multiple sclerosis": 13.32, "nephrotic syndrome": 13.61, "neuromyelitis optica spectrum disorder": 92.49, "neutropenia": 2.19, "off label use": 17.54, "oropharyngeal discomfort": 5.76, "oxygen saturation decreased": 5.86, "pneumonitis": 3.43, "polymyositis": 70.82, "product substitution issue": 54.71, "pruritus": 2.79, "rash maculo-papular": 3.72, "serum sickness": 54.08, "systemic lupus erythematosus": 12.13, "throat irritation": 13.18, "throat tightness": 7.55, "thrombocytopenia": 2.24, "underdose": 10.19, "urticaria": 2.95, "vasculitis": 5.39, "waldenstrom's macroglobulinaemia": 214.99}